Background {#Sec1}
==========

Cancer has become one of the most annihilating diseases globally with more than 10 million new cases annually. The compounds isolated from natural sources have been the source of most of the active components of medicines. One of the studies revealed that since 1994 50 % of the drugs approved are originated from natural sources. The drugs approved cover a variety of therapeutic indications, most of these are related to cancer treatment \[[@CR1]\]. It is evident from various studies that medicinally important plants including *Podophyllum peltatum*, *Taxus brevifolia*, and *Cantharanthus roseus* and many others provided bioactive compounds including podophyllotoxin, taxol, and vincristine etc. for the management of various cancers \[[@CR2]\]. There is always a need to search alternative sources with more effectiveness, more accessibility, and least side effects. Therefore, the present study was carried out to explore the anticancer activity of extracts and crude saponin fractions from *Zanthoxylum armatum* fruit, bark and leaves in cultured human breast cancer cells (MCF-7 and MDA MB-468) and colorectal cancer cell lines (Caco-2).

The genus Zanthoxylum have been explored for various activities based on traditional uses. The active metabolites isolated from these plants showed anti-cancer potential \[[@CR3]\]. A similar study available from the same genus is about *Zanthoxylum usambarense* (Engl.). In this study the extracts of *Z. usambarense* showed significant activity against breast cancer cell lines MCF-7 (IC~50~ 42.9 mg/mL) and revealed to have induced cell death through apoptosis \[[@CR4]\]. Another study showed that the plant *Zanthoxylum armatum* DC. extract has the ability to induce clumped chromosomes at metaphase stage of cell division coupled with mitotic arrest, DNA degradation, and chromatin condensation \[[@CR3]\].

*Zanthoxylum armatum* (DC) belongs to family Rutaceae. It is a common plant in Southeast Asia. In Pakistan it is found wild in Dir, Hazara, and Murree hills of Pakistan \[[@CR5]\]. The aerial parts of the plant are used in management of fever, dyspepsia, stomachic upset, cholera, and in toothache \[[@CR6]\]. The small branches of *Z. armatum* are used as tooth brush (miswak) for washing the teeth while the powder of fruit is applied in toothache \[[@CR7]\]. Many plants of *Zanthoxylum* genus possess antimicrobial, larvicidal and cytotoxic activity \[[@CR8]--[@CR11]\]. The different classes of chemical constituents reported from *Z. armatum* include terpenes, sterols, flavonoids, alkaloids, saponins, and coumarins \[[@CR5], [@CR12]--[@CR14]\].

Methods {#Sec2}
=======

Chemicals {#Sec3}
---------

Neutral red solution, Fetal Bovine serum (FBS), Actinomycin-D, Dulbecco's modified Eagle medium **(**DMEM) and 4, 6-diamidineo-2-phenylinldole (DAPI), MTT (methyl-thiazolyl tertrazolium), DMSO (dimthylsulphoxide) were obtained from Sigma Chemical Co. (St Lois, MO, USA). The drugs Gentamycin, Streptomycin, Glutamine, Actinomycin-D used in the experiments were also purchased from Sigma Chemical Co. (St Lois, MO, USA).

Cell lines {#Sec4}
----------

MCF-7 and MDA-MB-468 cells were purchased from ATCC (American Type Culture Collection, USA) through an authorized distributor, LGC Standards, Teddington, UK. The Caco-2 (human colon adenocarcinoma) cell line was obtained from the ECCC (European Collection of Cell Cultures) through Health Protection Agency, Salisbury, UK (Catalogue No. 86010202).

Plant material {#Sec5}
--------------

Five kg of each of leaves, bark and fruit of *Z. armatum* were collected from Mansehra, Tanawal area of KPK Pakistan in the month of August, 2013. After authentication from taxonomist, the plant and its voucher specimen (PB025.13) were deposited in the herbarium of the Post graduate college, Abbottabad. Each part of the plant was washed under running water and dried in shade at room temperature and was ground to coarse powder. The powder drug was stored in air tight and light resistant container before extraction.

Cell culture {#Sec6}
------------

A complete growth medium was provided for the cell growth: Dulbecco's modified Eagle medium **(**DMEM) containing 10% *v*/v FBS, 2 mM L-glutamine, Gentamycin (40 μg/ml), Penicillin (100 units/ml) and Streptomycin (1040 μg/ml). The cells were seeded into 96-well cell culture plates at a density of 1 × 10^4^ cells per well in 100 μl aliquots of the medium. The cells were permitted to attach for a period of 24 h, the temperature was maintained at 37 °C, and 5% CO~2~ in air, in a humidified atmosphere in an incubator.

Preparation of extract and crude saponins {#Sec7}
-----------------------------------------

The powder material (200 g each) of leaves, bark and fruit was extracted with methanol solvent using soxhlet extractor for 20 h. After filtering through Whatman Grade-I filter paper, the filtrate was evaporated under reduced pressure on a vacuum rotary evaporator at 40 °C. The separation of saponins from powdered materials (200 g) of leaves, bark and fruit was carried out first by defatting with petroleum ether. In the next step extraction was carried out with methanol in Soxhlet apparatus. Evaporation of the solvent was done under reduced pressure to obtain a semi solid extract. This extract of the plant was further fractionated with n-butanol and water in equal proportions. The n-butanol fraction was separated. Petroleum ether was added to the extract in small proportions to precipitate the crude saponins \[[@CR15]\]. Extractive yield (percent) of the methanol extracts were; bark (Zb): 21 ± 1%, leaves (Zl):19 ± 1%, and fruit (Zf): 14.34 ± 1%.

Preparation of the drug for the experiment {#Sec8}
------------------------------------------

The crude extract of the leaf, bark and fruit of *Z. armatum* were tested for cell cytotoxicity against breast and colorectal cancer cell lines. A series of eight dilutions (10, 25, 50, 100, 200, 300, 400 and 500 μg of final concentration) of crude extracts were prepared in DMEM (100 μl) containing DMSO (Dimethyl sulfoxide, maximum: 0.01%). After the initial screening results, a test dose of 200 μg for MTT assay and 100 μg for NRU assay was set for extracts based on their apparent IC~50~ values.

Cytotoxicity assays {#Sec9}
-------------------

After a 24 h exposure of test period, the determinations of toxic endpoints were carried out by two colorimetric methods namely; methyl-thiazolyl tertrazolium (MTT) assay and neutral red uptake (NRU) assay.

MTT (methyl-thiazolyl tertrazolium) assay {#Sec10}
-----------------------------------------

The quantification of cancer cells growth was carried out as described by \[[@CR16], [@CR17]\]. After test period of 24 h exposure to extract, the cells were washed with phosphate buffer saline (PBS) twice. 10 μl of MTT reagent (5 mg/ml in PBS) was poured to each well including the blanks (contained medium only). The plates were incubated for 4 h at 37 °C. Afterward, cells were washed with PBS twice, and 100 μl/well DMSO was added as a solvent to dissolve the insoluble crystalline formazan products. The effect of plant leaves, bark and fruit extracts on cancer cells was quantified as the percentage of control absorbance of reduced dye at 550 nm on a microplate reader (LabtechLT-4000MS, Labtechm International Ltd., East Sussex, and UK). Five replicates wells were examined for each treatment, and each experiment was repeated three times (*n* = 3) to calculate the standard error of mean. The results were calculated as percentage growth inhibition, untreated (control) cells versus treated cells according to the following formula:$$\documentclass[12pt]{minimal}
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Absorbance of the media was subtracted, both from control and treated cells.

NRU (neutral red uptake) assay {#Sec11}
------------------------------

This assay was performed as described by \[[@CR18]\]. The medium was removed after dosing cells. In the next step 200 μl of neutral red solution (40 μg/ml) was poured into each well of test solution and blank. The mixture was incubated for 2.5 h. and neutral red was removed. The cells were then rinsed with warm PBS carefully. 200 μl of ethanol/acetic acid (1% glacial acetic acid in 5% ethanol) was added to all wells. The 96 well plates were covered in foil. The plates were shacked for 30 min on shaker to separate neutral red dye from cells and to make the solution homogenous. The absorbance of the samples was measured within 60 min at 540 nm using a microplate reader. The samples were measured in replicates of five. Each experiment was performed three times (*n* = 3). The results were calculated by the same equation as already given for MTT assay.

Cytomorphological alterations (DAPI staining) {#Sec12}
---------------------------------------------

In this study, DAPI (4′, 6-diamidino-2-phenylindole) stain was used to evaluate the morphological changes in nuclei of control and treated cells. The cells were seeded at density of 1 × 10^4^ cells/well in 500 μl of medium on sterilized glass cover slips in 96 well plates for 24 h. The cells were treated with the culture medium (negative control) and Actinomycin-D (positive control, 4 μM). The plates were incubated at 37 °C, 5% CO~2~ in air in a humidified atmosphere for 24 h. After treatment, cells were briefly equilibrated with PBS, fixed with 4% paraformaldehyde for 15 min, permeabilised with methanol for 5 min, and mounted in a DAPI-containing medium (Vector Shield, Vector Labs, Peterborough, UK). The morphology of the nuclei was observed using a confocal fluorescence microscope, Leica SP2 AOBS confocal microscope (Leica Microsystems, Mannheim, Germany) with excitation at 350 nm and emission 460 nm under a ×40 oil objective \[[@CR19]\].

Data presentation and statistical analysis {#Sec13}
------------------------------------------

All data were compiled from a minimum of three experiments. Data for statistical analysis were expressed as 'standard error of the mean', n (number of experiments). The software used was GraphPad Prism version 6.00 for Windows, (GraphPad Software, San Diego California, USA). The test applied was Dunnett's test with one-way ANOVA.

Results {#Sec14}
=======

MTT assay {#Sec15}
---------

The methanol extract and crude saponins from leaves, bark and fruit of *Zanthoxylum armatum* were subjected to MTT assay using two breast cancer cell lines, MDA-MB-468 and MCF-7, and the colorectal cell line Caco-2 to assess potential cytotoxicity.

The methanol extract fruit (Zf), bark (Zb) and leaves (Zl) of *Z. armatum*, showed a concentration dependent growth inhibition from 10 to 500 μg/ml of MCF-7 cancer cell lines. The Zf showed more effective inhibition and highly significant activity was observed with extract concentration of 200 μg/ml as compared to Zb (400 μg/ml) and Zl (300 μg/ml).

Similarly, a concentration depended response was observed against the growth of MDA MB-468 cell lines and very high significance inhibition was observed above the concentration of 200 μg/ml for Zf and Zb. However, Zl extract showed maximum inhibition over 300 μg/ml. The methanol extracts of fruit, bark and leaves of *Z. armatum* showed a concentration depended inhibition of Caco-2 cancer cell lines growth in tested concentration range of 10--500 μg/ml. The very high significance inhibition of the growth was observed above the concentration of 200 μg/ml for Zf and 300 μg/ml for Zb. However, Zl extract proved least active and showed maximum inhibition over 500 μg/ml. (Table [1](#Tab1){ref-type="table"}).Table 1Cytotoxic activity of crude extract of Z*. armatum* using MTT assay with apparent IC~50~ about 200 μg/mlConc. (μg/ml)*Z. armatum fruit extract (Zf)Z. armatum leaves extract (Zl)Z. armatum bark extract (Zb)*MCF-7 cellsMDA MB-468 cellsCaco-2 cellsMCF-7 cellsMDA MB-468 cellsCaco-2 cellsMCF-7 cellsMDA MB-468 cellsCaco-2 cells1021.58\* ±3.29.8 ± 3.615.96\* ±6.83.56 ± 1.80.87 ± 0.43.83 ± 2.34.25 ± 3.816.51 ± 4.65.21 ± 1.42537.50\*\* ± 4.112.72\* ±3.027.97\* ±2.12.79 ± 1.02.50 ± 0.54.10 ± 2.16.08 ± 2.027.54\* ±3.216.33 ± 1.25035.45\*\* ± 8.622.78\* ±1.949.25 \*\* ± 5.011.22 ± 2.64.11 ± 0.98.60 ± 4.37.46 ± 5.542.25\*\* ±3.412.63 ± 3.210035.22\*\* ± 5.138.90\*\* ± 3.953.93\*\*\* ±4.026.14\* ±5.06.23 ± 1.414.21 ± 2.011.18 ± 4.046.22\*\* ±4.620.52\* ±1.420058.28\*\*\* ± 4.857.26\*\*\* ± 4.464.95\*\*\* ±4.235.71\*\* ±4.720.97\* ±2.321.05\* ± 4.417.28 ± 3.974.39\*\*\* ±2.839.38\*\* ±4.830065.74\*\*\* ± 7.869.48\*\*\* ± 4.775.60\*\*\* ±8.554.35\*\*\* ± 4.641.97\*\* ±1.128.56\* ± 2.323.06\* ± 3.274.87\*\*\* ±3.962.72\*\*\* ±3.040073.70\*\*\* ± 10.285.15\*\*\* ± 2.888.90\*\*\* ±5.863.77\*\*\* ± 3.299.58\*\*\* ±0.241.63\*\* ± 4.759.21\*\*\* ±2.984.24\*\*\* ±6.463.56\*\*\* ±4.750095.88\*\*\* ± 6.090.54\*\*\* ±6.894.24\*\*\* ±4.378.63\*\*\* ± 4.299.35\*\*\* ±0.550.14\*\*\* ± 3.571.15\*\*\* ±2.699.76\*\*\* ±0.768.37\*\*\* ±2.8Veh. Cont.2.87 ± 0.64.92 ± 2.91−2.10 ± 0.21.10 ± 1.131.57 ± 3.61.68 ± 5.21.69 ± 4.41.67 ± 1.01.76 ± 5.1In the table statistically (Dunnett's multiple comparison test) \* = Significant (*P* \< 0.05), \*\* = Highly significant (*P* \< 0.01), \*\*\* = Very highly significant (*P* \< 0.001)

The effect of saponins of *Z. armatum* fruit (Zf.Sa), bark (Zb.Sa) and Leaves (Zl.Sa) against cell lines MCF-7 and MDA MB-468 tested at a concentration of 100 μg/ml in MTT assays. The saponins Zf.Sa showed growth inhibition of MCF-7 and MDA-MB-468 by 79.89 (±7.45) % and 95 (±2.64) % respectively, the saponins Zb.Sa inhibited the growth by 9.43 (± 3.82) and 94.59 (± 3.00) and saponins of Zl.Sa inhibited with growth by 49.08 (± 5.21) and 85.33 (± 3.41) respectively with respect to Actinomycin-D (4 μM***)*** which showed the growth inhibition of 62.04 (±1.43) % and 62.87 (±5.28) % respectively. The effect of Zf.Sa, Zb.Sa and Zl.Sa against cancer cells Caco-2 were tested at dose of 200 μg/ml for MTT assays. The saponins showed maximum effect and inhibited the growth of Caco-2 by 75.88 (±8.41) %, 61.82 (± 4.07) and 68.62 (± 2.48) respectively with respect to Actinomycin-D (4 μM***)*** which showed the growth inhibition of 65.40(±4.29) % (Table [2](#Tab2){ref-type="table"}).Table 2Cytotoxic activity of saponins fractions (200 μg/ml) from *Z. armatum* using MTT assayFractions (200 μg/ml)Percentage growth inhibition of cancer cells (Mean ± Std. Dev.)MCF-7 cellsMDA MB-468 cellsCaco-2 cellsVehicle Control*Zf.Sa*79.69\*\*\* (±7.45)95.00\*\*\* (±2.64)75.88\*\*\* (±8.41)3.17 (±5.67)*Zl.Sa*49.08\*\* (±5.21)85.33\*\*\* (±3.41)68.62\*\* (±2.48)3.43 (±6.80)*Zb.Sa*9.43 (±3.82)94.59\*\*\* (±3.00)61.82\*\* (±4.07)0.20 (±2.34)*Actinomycin-D (4* μM*)*62.04\*\* (±1.43)62.87\*\* (±5.28)65.40\*\* (±4.29)1.10 (±1.13)In the table statistically (Dunnett's multiple comparison test) \* = Significant (*P* \< 0.05), \*\* = Highly significant (*P* \< 0.01), \*\*\* = Very highly significant (*P* \< 0.001)

NRU assay {#Sec16}
---------

The *Z. armatum* Zf, Zb and Zl extracts showed the dose dependent growth inhibition of the MCF-7 and MDA MB-468 cancer cell lines from 10 to 500 μg/ml concentrations in NRU assay. Zf and Zb showed highly significance response with concentration of 100 μg/ml. Zl showed maximum response above the concentration of 300 μg/ml. The Zf, Zb and Zl showed the inhibition of the Caco-2 cancer cell lines and highly significance responses were observed with dose of 200 μg/ml for Zf and 400 μg/ml for Zb and Zl (Table [3](#Tab3){ref-type="table"}).Table 3Cytotoxic activity of crude extract of *Z. armatum* using (NRU) neutral red uptake assay with apparent IC~50~ 100 μg/mlConc. (μg/ml)*Z. armatum fruit saponins (Zf.Sa)Z. armatum leaves saponins (Zl.Sa)Z. armatum bark saponins (Zb.Sa)*MCF-7 cellsMDA MB-468 cellsCaco-2 cellsMCF-7 cellsMDA MB-468 cellsCaco-2 cellsMCF-7 cellsMDA MB-468 cellsCaco-2 cells1016.02\* ± 7.513.98 ± 3.925.76\* ±2.12.71 ± 0.513.92 ± 3.65.74 ± 4.020.04\* ±4.44.43 ± 1.43.64 ± 0.42527.89\* ±6.129.60\* ±3.926.60\* ± 4.23.07 ± 1.228.27\* ± 3.27.42 ± 1.745.78\*\* ±5.16.31 ± 1.24.46 ± 3.05046.82\*\* ±6.139.31\*\* ± 3.930.52\*\* ± 4.33.51 ± 1.425.76\* ± 4.113.87 ± 5.066.05\*\*\* ±6.09.55 ± 0.94.03 ± 3.810058.08\*\*\* ±7.153.53\*\*\* ±3.942.99\*\* ± 3.34.27 ± 2.152.61\*\* ± 5.610.18 ± 4.172.23\*\*\* ±3.228.91\* ±5.019.59 ± 3.120058.75\*\*\* ±4.055.75\*\*\* ±3.959.78\*\*\* ±6.734.39\*\* ±2.977.43\*\*\* ± 5.432.90\*\* ± 8.283.29\*\*\* ±3.699.36\*\*\* ±0.622.85 ± 5.130071.62\*\*\* ±4.866.62\*\*\* ± 3.972.47\*\*\* ±5.693.73\*\*\* ±2.099.04\*\*\* ± 1.630.13\*\* ± 2.592.55\*\*\* ±5.8100.00\*\*\* ±0.230.98\*\* ±8.440080.89\*\*\* ±6.273.72\*\*\* ±3.991.78\*\*\* ±3.6100.71\*\*\* ± .01100.14\*\*\* ± 1.356.45\*\*\* ± 2.698.78\*\*\* ±1.2100.00\*\*\* ±0.366.03\*\*\* ±5.450086.18\*\*\* ±4.693.29\*\*\* ±3.996.86\*\*\* ±2.9100.81\*\*\* ±0.2100.14\*\*\* ± 0.563.97\*\*\* ± 3.499.08\*\*\* ±1.0100.00\*\*\* ±0.690.01\*\*\* ±3.1Veh. Cont.−1.49 ± 1.01.38 ± 0.9−3.45 ± 1.84.41 ± 2.21.91 ± 1.61.35 ± 3.71.72 ± 1.45.21 ± 3.0−1.81 ± 0.9In the table statistically (Dunnett's multiple comparison test) \* = Significant (*P* \< 0.05), \*\* = Highly significant (*P* \< 0.01), \*\*\* = Very highly significant (*P* \< 0.001)

The effect of saponins of *Z. armatum* fruit (Zf.Sa), bark (Zb.Sa) and Leaves (Zl. Sa) against cancer cells MCF-7 and MDA MB-468 were tested at concentration of 100 μg/ml in NRU assays. The saponins Zf.Sa showed inhibition of MCF-7 and MDA MB-468 by 81.67 (±4.15) % and 93.81(±2.32) % respectively, the saponins Zb.Sa inhibited the growth by 7.77 (± 4.83) and 95.25 (± 4.35) and saponins of Zl. Sa inhibited with growth by 48.58 (±7.36) and 71.19(± 2.76) respectively with respect to Actinomycin-D (4 μM***)*** which showed the growth inhibition of 62.04 (±1.43) % and 62.87 (±5.28) % respectively. The crude saponins Zf.Sa, Zb.Sa and Zl.Sa inhibited the growth of Caco-2 by 53.16 (±3.31) %, 66.43 (± 3.24) % and 45.96 (± 10.67) % respectively with respect to Actinomycin-D (4 μM*)* which showed the growth inhibition of 65.40(±4.29) %. (Table [4](#Tab4){ref-type="table"}).Table 4Cytotoxic activity of saponins fractions (100 μg/ml) from *Z. armatum* using NRU assayFractions (100 μg/ml)Percentage growth inhibition of cancer cells (Mean ± Std. Dev.)MCF-7 cellsMDA MB-468 cellsCaco-2 cellsVehicle Control*Zf.Sa*81.67\*\*\* (±4.15)93.81\*\*\* (±2.32)53.16\*\*\* (±3.31)−0.19 (±2.68)*Zl.Sa*48.58 (±7.36)71.19 (±2.76)45.96 (±10.67)4.23 (±7.80)*Zb.Sa*7.77 (±4.83)95.25\*\*\*(±4.35)66.43(±3.24)2.92(±3.20)*Actinomycin-D (4* μM*)*91.84\*\*\* (±3.73)93.94\*\*\* (±5.02)65.97\*\* (±4.83)1.67 (±1.06)In the table statistically (Dunnett's multiple comparison test)\* = Significant (*P* \< 0.05), \*\* = Highly significant (*P* \< 0.01), \*\*\* = Very highly significant (*P* \< 0.001)

DAPI staining {#Sec17}
-------------

The DAPI staining of cancer cells lines were carried out for only those fractions of saponins with highly significant growth inhibition in MTT and NRU assay. Zf.Sa saponins showed prominent activity against all three cell lines (A3, B3 and C3). Microscopic examination revealed that the cells lost their shapes and were shrunken. It was a clear indication of nuclear fragmentation and chromatin condensation. It was very clear that the numbers of apoptotic cells were higher as compared to untreated cells (Control). The crude saponins isolated from leaves (Zl.Sa) and bark (Zb.Sa) were evaluated against MDA MB-468 breast cancer cells and were stained with DAPI. The treated cells showed similar results and revealed nuclear fragmentation and chromatin condensation. The saponins from bark and leaves showed no prominent activity against caco-2 cancer cell lines (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Cytmorphology of control cells (**a** = MCF-7, **b** = MDA MB-468, **c** = CaC02). Saponins from *Z. armatum* Zf treated cells (**a3**, **b3**, **c3**), Zb treated cells (**a4**), Zl treated cells (**b4**). (Cells were treated with most active saponins (10 μg/ml, final concentration) for 24 h and visualized under confocal microscope for DAPI stain)

Discussion {#Sec18}
==========

Screening of herbal drugs may lead to discovery of new mutagenic agents which can be an alternative source to the costly anticancer chemotherapeutic agents. Due to low toxicity and less cost, some medicinal plants have attracted the attention as alternative cancer therapies \[[@CR20]\]. The plants of genus Zanthoxylum have been traditionally used since ancient times and have been of much interest due to historical claims of anticancer properties. In general, several other species of the genus Zanthoxylum have previously been shown to possess cytotoxicity against various human cancer and tumor cell lines. Thus, the cytotoxic activity of the extracts of *Z. armatum*, observed in the present study, corresponds well with the cytotoxic potential of this genus \[[@CR21]\]. An example of such evidence is of traditional Chinese medicine *Z. nitidum,* which has been reported to inhibit breast cancer cell lines \[[@CR22]\].

MTT assay has been used to determine number of viable cells in an anticancer investigation \[[@CR23]\]. Mitochondrial dehydrogenase (MD) produced by normal cells reduce MTT (Yellow) to formazan (blue). In dead cells MD lacks this activity and reduction of MTT not occurred \[[@CR24]\]. MTT assay result showed that *Z. armatum*, the fruit extract showed significance inhibition of all the three cell lines in MTT assay. The bark and leaves saponins/extract of *Z. armatum* were significantly active against MDA MB-468 cells only while mild activity was observed against MCF-7 and Caco-2 cells. The neutral red uptake (NRU) assay also showed similar results for *Z. armatum* and inhibited the three cell lines in a manner observed in MTT assay.

Further studies were carried out on precipitated saponins fractions. Over 100 and 50 saponins from natural sources have been tested and found to be effective against different types of cancers. Due to this diversity in structure the saponins exert anticancer effect through variety of mechanisms and pathways. One of example is of steroidal saponins which induce apoptosis and cell cycle arrest of tumors \[[@CR25]\]. Another report revealed that there is a growing interest in clinical use of saponins as chemotherapeutic agent. More than 400 reports are available about ability of saponins to induce apoptosis in treating cancer \[[@CR26]\]. In one such study saponins compounds were experimented against colon cancer cell lines and it was found that saponins inhibited the tumor cells growth without altering the normal colon morphology \[[@CR27]\]. Apoptosis is a programmed process of cell death. It occurs in pathological and physiological conditions. A defect in apoptotic pathways has an important role in carcinogenesis. In apoptosis, the chromatin condenses, the cells shrink, the DNA fragment and apoptotic bodies are formed. These all together are the characteristic of apoptosis \[[@CR28]\]. It is reported that saponins exert its cytotoxic activity through apoptosis through signaling pathways to prevent the tumor \[[@CR29]\]. The induction of apoptosis for the prevention of cancer is therefore desirable.

There are evidences available from the previous studies that indicates the cytotoxic potential of *Z. alatum* leaves. One such study was carried out against the Ehrlich ascites carcinoma in which the isolated compound Zanthonitirle showed the cytotoxic effect in dose dependent manner \[[@CR30]\]. Another study also revealed the cytotoxic potential of lignans isolated *Z. alatum* against the pancreatic and lung carcinoma cell lines \[[@CR31]\].

Here, we have studied the cytotoxic and apoptotic potential of the Zf.Sa, Zb.Sa and Zl.Sa on human cancer cell lines. The evidence already exist that the extracts of *Z. armatum* DC exert its cytotoxic potential by mechanisms involving apoptosis \[[@CR3]\]. DAPI staining is most commonly used assay for observing the apoptosis at DNA level \[[@CR19]\]. In this study saponins from *Z. armatum* fruit (Zf.Sa) induced morphological changes in apoptotic cells which were observed in DAPI staining. The confocal microscopy demonstrates that the treatment with saponins (Zf.Sa) resulted in apoptotic body formation, chromatin condensation and nuclear fragmentation. It clearly indicates the potential of saponins to induce apoptosis against cancer cell lines.

Conclusion {#Sec19}
==========

In conclusion, the current study clearly demonstrates that the extract and crude saponins from fruit, bark and leaves of traditional medicinal plant *Zanthoxylum armatum* DC., has the potential to exert its cytotoxic effect on cancer cell lines isolated from human by a mechanism involving apoptosis. The overall finding demonstrate that this plant could be a potential source of new anticancer compounds for possible drug development against cancer.
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